PharmGKB's aim is to aid researchers in understanding how genetic variation among individuals contributes to differences in reactions to drugs. It is funded by the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS), and is a partner of the NIH Pharmacogenomics Research Network (PGRN).Number of Partnerships: 10
